Press releases Image EN FR Proton Therapy / 21.12.2015 IBA to Install New Proteus®ONE Proton Therapy System in Taiwan Read more IBA to Install New Proteus®ONE Proton Therapy System in Taiwan
Press releases Image EN FR Corporate / 14.12.2015 Full disposal of IBA Molecular by IBA S.A. Read more Full disposal of IBA Molecular by IBA S.A.
Press releases Image FR EN Corporate / 17.11.2015 IBA Trading Update - Third Quarter 2015 Read more IBA Trading Update - Third Quarter 2015
Press releases Image EN FR Proton Therapy / 13.11.2015 IBA Signs Final Contracts to Install Three Compact Proton Therapy Centers in the United Kingdom Read more IBA Signs Final Contracts to Install Three Compact Proton Therapy Centers in the United Kingdom
Press releases Image EN Proton Therapy / 20.10.2015 Pencil Beam Scanning technology takes proton therapy services for Korean cancer patients another step forward Read more Pencil Beam Scanning technology takes proton therapy services for Korean cancer patients another step forward
Press releases Image EN Proton Therapy / 19.10.2015 Breast cancer patient first to benefit from Cone Beam CT- supported setup for Proteus®ONE treatment session Read more Breast cancer patient first to benefit from Cone Beam CT- supported setup for Proteus®ONE treatment session
Press releases Image EN Proton Therapy / 21.09.2015 IBA signs contract to install Latin America’s first proton therapy center in Argentina Read more IBA signs contract to install Latin America’s first proton therapy center in Argentina
Press releases Image EN FR Corporate / 31.08.2015 IBA – Data Concerning Transparency Read more IBA – Data Concerning Transparency
Reports Image EN FR Corporate / 28.08.2015 IFRS Interim Condensed Consolidated Financial Statements June 30, 2015 Read more IFRS Interim Condensed Consolidated Financial Statements June 30, 2015
Press releases Image EN FR Corporate / 27.08.2015 IBA Reports Half Year 2015 Results Read more IBA Reports Half Year 2015 Results
Press releases Image EN FR Corporate / 03.08.2015 IBA Molecular North America, Inc. acquisition by Illinois Health and Science completes Read more IBA Molecular North America, Inc. acquisition by Illinois Health and Science completes
Press releases Image EN Proton Therapy / 12.07.2015 Willis Knighton Cancer Center reports 9 months of operations on Proteus®ONE: the first and only compact IMPT solution Read more Willis Knighton Cancer Center reports 9 months of operations on Proteus®ONE: the first and only compact IMPT solution
Press releases Image EN FR Proton Therapy / 01.07.2015 IBA adds two treatment rooms to South China Guangdong collaboration Read more IBA adds two treatment rooms to South China Guangdong collaboration
Press releases Image EN FR Proton Therapy / 25.06.2015 IBA to Install Three Compact Proton Therapy Centers in the United Kingdom Read more IBA to Install Three Compact Proton Therapy Centers in the United Kingdom
Press releases Image FR EN Proton Therapy / 12.06.2015 IBA and Philips India to Introduce Proton Therapy Cancer Treatment in India Read more IBA and Philips India to Introduce Proton Therapy Cancer Treatment in India
Press releases Image EN Corporate / 01.06.2015 IBA to Present at the Jefferies 2015 Global Healthcare Conference Read more IBA to Present at the Jefferies 2015 Global Healthcare Conference
Press releases Image EN FR Corporate / 13.05.2015 IBA Trading Update - First Quarter 2015 Read more IBA Trading Update - First Quarter 2015
Press releases Image EN FR Proton Therapy / 22.04.2015 IBA Signs Formal Contract to Install the First Proton Therapy Center in The Netherlands Read more IBA Signs Formal Contract to Install the First Proton Therapy Center in The Netherlands
Press releases Image EN Corporate / 17.04.2015 IBA Molecular North America, Inc. to be Acquired by Illinois Health and Science Read more IBA Molecular North America, Inc. to be Acquired by Illinois Health and Science
Press releases Image EN Proton Therapy / 07.04.2015 IBA User Meeting: joining forces to drive proton therapy forward Read more IBA User Meeting: joining forces to drive proton therapy forward